Is it safe for a patient with an implanted cardioverter‑defibrillator (ICD) and stable cardiovascular status, not taking nitrates, to use sildenafil (Viagra)?

Sildenafil (Viagra) is safe to use in patients with an ICD who have stable cardiovascular status and are not taking nitrates.

The presence of an ICD itself is not a contraindication to sildenafil use. The critical safety considerations relate to the patient's overall cardiovascular stability and concurrent medications—specifically the absolute contraindication with nitrates—not the device itself 1.

Key Safety Principles

Absolute Contraindication: Nitrates

Sildenafil must never be used with nitrate medications in any form due to the risk of severe, potentially life-threatening hypotension 2. This is the only absolute contraindication and applies to:

• Nitroglycerin (sublingual, spray, patches, ointments)
• Isosorbide mononitrate and dinitrate
• Recreational nitrates ("poppers")

The required washout periods are 2:

• 24 hours after sildenafil or vardenafil before nitrates can be given
• 48 hours after tadalafil before nitrates can be given

Cardiovascular Stability Assessment

Before prescribing sildenafil to any patient with cardiovascular disease (including those with ICDs), assess whether the patient can safely engage in sexual activity 2:

Sexual activity requires approximately 3-5 metabolic equivalents (METs) of exertion. If the patient can achieve this level during exercise testing without ischemia or symptoms, the risk during sexual activity is low 2.

For patients with ICDs who are:

• Functionally well-compensated
• Free of ongoing or frequent angina
• Not experiencing hemodynamic instability
• Able to perform moderate physical activity

Sexual activity and sildenafil use are reasonable 2.

ICD-Specific Considerations

The ICD itself does not interact with sildenafil pharmacologically. ICDs are implanted for:

• Secondary prevention (survivors of cardiac arrest, sustained VT/VF)
• Primary prevention (reduced ejection fraction with heart failure)

What matters is the underlying cardiac condition, not the device. If the patient's cardiovascular status is stable enough to warrant only device therapy (rather than being hospitalized or requiring intensive medical management), they can typically use sildenafil safely 3.

Hemodynamic Effects of Sildenafil

Sildenafil causes mild, predictable blood pressure reductions 4, 5:

• Approximately 8 mmHg systolic and 5-7 mmHg diastolic
• Does not affect cardiac contractility
• Does not increase ventricular arrhythmia risk
• Does not negatively impact coronary oxygen consumption or exercise capacity in stable CAD

These modest hemodynamic changes are well-tolerated in patients with stable cardiovascular disease, including those with ICDs 4, 5, 6.

Medication Interactions to Monitor

Beyond nitrates, exercise caution with:

Alpha-blockers: Coadministration may cause symptomatic hypotension 4. Patients should be:

• Stable on alpha-blocker therapy first
• Started on the lowest sildenafil dose (25 mg)

Antihypertensives: Generally safe, though additional blood pressure lowering occurs (e.g., 8/7 mmHg additional reduction with amlodipine) 4.

Clinical Approach

For a patient with an ICD asking about sildenafil:

1. Verify nitrate status: Confirm the patient is not taking any form of nitrates and understands they cannot use nitrates within 24 hours of sildenafil
2. Assess cardiovascular stability: Ensure no recent decompensation, ongoing ischemia, or hemodynamic instability
3. Evaluate functional capacity: If uncertain, consider exercise testing to confirm ability to achieve 3-5 METs
4. Review other medications: Check for alpha-blockers or multiple antihypertensives
5. Start appropriately: Begin with 50 mg (or 25 mg if >65 years, hepatic/renal impairment, or on CYP3A4 inhibitors) 7, 8
6. Provide emergency instructions: Educate that if chest pain occurs after sildenafil use, they must inform emergency personnel about sildenafil use, as nitrates cannot be given 1

Common Pitfall

Do not confuse the ICD device with a contraindication. The device is a marker of underlying cardiac disease, but stable patients with ICDs who meet cardiovascular criteria can safely use sildenafil. The focus should be on current cardiac status, functional capacity, and medication interactions—particularly nitrates—not on the presence of the device itself.